📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Considerations for using potential surrogate endpoints in cancer screening trials. (2024)

First Author: Webb AB

Attributed to: Developing Existing Healthcare Technologies to Deliver More Affordable and Effective Cancer Care funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/s1470-2045(24)00015-9

PubMed Identifier: 38697164

Publication URI: http://europepmc.org/abstract/MED/38697164

Type: Journal Article/Review

Volume: 25

Parent Publication: The Lancet. Oncology

Issue: 5

ISSN: 1470-2045